Skip to main content

Find Clinical Trials

Home
Conditions
Secondarily Infected Traumatic Skin Lesions

Clinical trial condition

Secondarily Infected Traumatic Skin Lesions

Explore clinical trials studying Secondarily Infected Traumatic Skin Lesions. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Secondarily Infected Traumatic Skin Lesions trial results

Completed

To Compare the Safety and Efficacy of Perrigo's Product to an FDA Approved Product for the Treatment of Secondarily Infected Traumatic Skin Lesions

NCT04155203

Conditions: Secondarily Infected Traumatic Skin Lesions
Locations: Palm Beach Research Center West Palm Beach, Florida, United States

View Trial Details

Completed

A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.

NCT01876550

Conditions: Secondarily Infected Traumatic Skin Lesions
Locations: Not specified

View Trial Details